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ABSTRACT 
Carboxymethyl glucan (CM glucan) is a water soluble polysaccharide modified from the insoluble β-(1→3)-glucan by 
carboxymethylation. CM glucan has biological activities consistent with its insoluble form. Solubility improvement enables 
application as a biomaterial for pharmaceutical and cosmetic aspects. Microbial formation of CM glucan is mainly from Baker.s 
yeast. In addition, Brewer.s yeast is now present as the sufficient source for commercial CM glucan. The cosmetic ingredient 
properties of CM glucan was investigated both in in vitro and clinical studies of which the CM glucan promises as an efficient 
ingredient offering anti-aging and anti-wrinkle effects in addition to nourishing effect including skin lightening efficacy.  
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Introduction  
§Nowadays, world consumers focus more on their 
health and appearance. This trend is creating heightened 
demand for products formulated with natural ingredients.
1
 
Consumers worldwide are looking for personal care 
products that supply multiple benefits, for example, 
antioxidant, anti-wrinkle, and skin lightening effects, with 
minimal adverse effects.
2
  
Beta-glucans (β-glucans) are natural polysaccharides 
composed of D-glucopyranosyl units commonly found in 
wheat, oat, barley, microorganisms and fungi.
3-4
 The D-
glucopyranosyl units of glucans from cereal grains are 
linked by β-(1→4) and β-(1→3) bonds, whereas the 
glucans from yeast and higher fungi consist of a linear β-
(1→3) backbone with occasional β-(1→6) branching.
5
 
The frequency of branching and the length of the side 
chains are characteristic properties of each glucan 
isolated from various sources
(6)
 which are appropriate 
and available for a variety of applications. Glucan from 
cereal grains are valuable nutrients of the human diet 
                                                 
§
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while the crude preparation from cell wall of baker.s 
yeast (Saccharomyces cerevisiae) has been used for 
both cosmetic and pharmaceutical purposes for a long 
time regarding its antioxidant activity.
7-10
 The glucan of S. 
cerevisiae which has branching at every eighth unit has 
been used as folk medicine for curing tuberculosis, 
diarrhea, diabetes, etc, in addition to treating skin 
condition such as impetigo and acne.
11
 In 1941, there 
was the first discovery of pharmaceutical insoluble yeast 
product called :Zymosan< which composed of 50% 
glucan and other polysaccharaides, proteins and lipids.
12
 
This pharmaceutical product has been identified and 
proved as the immunological stimulator by activating 
macrophages, neutrophils and other cells that carry 
specific β-glucan receptors on the surface. It efficiently 
accelerates wound healing with advanced reepithelization 
and a reduction in the number of inflammatory cells at 20 
- 100 µg/mL. It could be useful in infectious diseases, 
oncology and other dermatological purposes.
13,14 
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Despite its polar nature, β-glucan is water insoluble 
particulate polymer which is not suitable for personal 
care products. It also produces undesirable toxicological 
properties which are significant adverse effects such as 
granuloma formation.
15
 In an attempt to modify the yeast 
glucan to be a soluble glucan by chemical reactions, 
derivatizations of β-glucan by means of carboxy-
methylation, sulfation and phosphation were widely 
developed.
16-18
 Carboxymethyl glucan or CM glucan, one 
of the modified water soluble derivative showed an 
antioxidant with the scavenging ability lying between αB
tocopherol and manitol.
19
 A soluble phosphorylated 
glucan had been successfully derived and this soluble 
derivative promoted the healing of a variety of wound 
types such as decubitus (or bedsore), burn and surgical 
wounds.
20
 Another soluble glucan was tested in phase I 
clinical trials in patients suffering from Acquired Immune 
Deficiency Syndrome (AIDS).
21
 Preparations of 
conjugates with chemotherapeutic agents was to 
enhance the effectiveness and reduce the toxicity of 
these drugs.
22 
 
Modification of yeast glucan to carboxymethyl 
glucan (CM glucan) 
A specialized procedure modified the insoluble β-
(1→3)-glucan to carboxymethyl glucan at C-7 position as 
shown in Figure 1. The carboxymethylation takes place 
under specific conditions with a degree of substitution of 
0.75. This suggests that three of four glucose units are 
modified to carboxymethyl glucose. This level of 
substitution is high enough to render the material water 
soluble without disturbing its helical structure, the 
configuration responsible for its activity. The chemical 
identity of the structure of CM glucan was analysed using 
different techniques of chromatography and spectro-
scopy.
23-25
 The comparison of signals from CM glucan 
with spectroscopic data of the yeast glucans provided by 
the literatures is shown in Table 1 of which the expected 
additional signals of carboxymethylation was found at C-
7, C-8 and C-9 positions. Although commercial carboxy-
methyl glucan is mainly obtained from microbial prepara-
tion
 26-30
, there is an alternative source from Poria 
cocos.
31
  
 
 
 
 
 
 
 
 
   
                                            (1)                                    (2) 
Figure 1 Structure of β-(1,3:1,6) glucan (1) and carboxymethylated β-(1,3) glucan
 
or CM glucan
 
(2)
32 
 
General properties of CM glucan 
The modification into a water soluble form affords CM 
glucan in a white powder and water soluble at 
concentration up to 4%. Up to 0.1%, CM glucan on 
fibroblast cultures do not exert any cytotoxic effects and 
the solution of CM glucan is slightly viscous, forms a thin 
film on the skin and gives a smooth sense effect to the 
skin like hyaluronic acid.  
CM glucan is neither an irritant/photo-irritant nor a 
sensitizer/photo-sensitizer and well tolerated in 33 
volunteers using 2% aqueous solution.
23
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Table 1 Comparison of 
13
C NMR (ppm) between 
insoluble glucan and soluble CM glucan.
23
  
C-atom Insoluble glucan CM glucan 
C-1 103.0 102.7 
C-2 72.8 74.6 
C-3 86.2 84.5 
C-4 68.4 69.5 
C-5 76.3 76.5 
C-6 60.8 59.4 
C-7 - 70.8 
C-8 - 71.6 
C-9 - 178.0 
 
Biological activity of CM glucan and cosmetic 
applications 
CM glucan was found able to stimulate keratinocyte 
proliferation. In a study, activity of two different 
concentrations (0.01 and 0.005%) of CM glucan in 
cultured porcine keratinocyte proliferation in M199 culture 
medium containing 10% calf serum (n = 4) was 
investigated. 0.01% CM glucan increased the relative cell 
count more than 40% after 120 hours. This led to a 
conclusion that the polysaccharide significantly stimulates 
the keratinocyte proliferation.
33
 
In a study on human keratinocytes and fibroblasts, CM 
glucan was used in the pretreatment for protecting 
culture cells against oxidative stress before exposing to 
UVA radiation (320 - 400 nm) at a dose rate of 300 Wm
-2
 
for different time periods. The contents of glutathione 
(GSH) and total protein (ferritin) were determined by 
enzymatic assay immediately after UV radiation and 24 
hours and α-tocopherol was used as a control. At 100 
µg/mL, CM glucan clearly showed protective effects 
against oxidative stress induced by UVA radiation. This 
protective effect of CM glucan was similar to that of α-
tocopherol (10 µM) but with a different mechanism. 
Furthermore, CM glucan did not show phototoxic effects 
on cultured human skin fibroblasts and keratinocytes.
34
 
In a clinical study, the formulation of CM glucan at 
various concentrations (0.04 - 0.4%) of hydrogel and oil-
in-water (o/w) emulsion were used as a pretreatment on 
five volunteers. forearms for evaluation of skin humidity 
protective effects caused by a challenge with 10% 
sodium dodecyl sulfate over a period of 2 weeks (n = 5). 
All formulations enhanced the skin humidity compared to 
the untreated skin. The protective effects against the skin 
humidity reduction depends on the CM glucan 
concentration, e.g. 0.4% CM glucan in o/w emulsion 
resulted in a percentage of protective skin humidity 
higher than those using 0.1% hydrogel and 0.04% o/w 
emulsion formulations.
33
 Additionally, the renewal of the 
stratum corneum was determined by the gradual 
diminution of a fluorescence set at the onset of the 
experiment by dansyl chloride. 0.4% CM glucan in o/w 
emulsion enhanced renewal rate of the stratum corneum 
more than 30% compared with untreated skin.
35
  
CM glucan inhibited lipid peroxidation caused by 
irradiation. A study randomly assigned 10 volunteers to 
apply different concentrations of CM glucan (0, 0.04 and 
0.2%) in o/w emulsion on the forearm twice daily for five 
days before UVA irradiation (10 Jcm
-2
). Squalene 
hydroperoxide concentration was measured in 
chemiluminescence units after lipid extractions from 
irradiated skin sites compared with that from a non-
irradiated area as a control. With the use of CM glucan 
at 0.04% in o/w emulsion, the squalene hydroperoxide 
concentration was reduced from 74.2% to 25.3%. For 
those pretreated with 0.2% CM glucan in o/w emulsion, 
squalene hydroperoxide concentrations from irradiated 
and non-irradiated areas were similar. Therefore, CM at 
the concentration of 0.2% in o/w emulsion inhibited lipid 
peroxidation almost completely.
36-39
  
Anti-wrinkle efficacy of 0.04% CM glucan in o/w 
emulation was tested on 10 volunteers aged over 60 
years by twice daily application around eyes and 
forearm. The 0.04% CM glucan emulsion significantly 
improved skin condition within 28 days as the skin was 
firmer and the eye wrinkle depth was reduced.
40
 
In addition to baker.s yeast CM glucan application, 
cosmetics containing Brewer.s yeast CM glucan was also 
formulated, stability and preference was tested and was 
clinically evaluated. It was found that the formulation 
containing 0.1% of CM glucan was stable with good 
spreadability and skin soothing effect. Regarding safety, 
the following patch tests showed negative result. For 
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further efficacy evaluation, the volunteers significantly 
had lighter skin and smoother texture showing nourishing 
effects followings 8 weeks of application (P = 0.015 and 
P < 0.001, respectively). In addition, the skin smoothness 
was improved (P = 0.031) as well as skin firmness (P < 
0.01). The skin lightening and firming effects were due to 
CM glucan property that enhanced a renewal rate of 
stratum corneum which further reduced melanin in 
stratum corneum. Finally this newly generated skin 
potentially resulted in increased skin moisture and 
firmness.
32
 
 
Conclusion 
CM glucan is the water soluble derivative of the 
insoluble β-glucan. It posses biological activities 
consistent with its water insoluble form. CM glucan was 
found promising as an active ingredient in skin 
nourishing, anti-wrinkle and anti-aging cosmetics. In 
addition to the baker.s yeast which is the main microbial 
production of CM glucan, Brewer.s yeast is now an 
alternative microorganism available for CM glucan.  
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